Status:
UNKNOWN
Study of a Series of Patients Treated for Retrograde Cricopharyngeal Muscle Dysfunction Syndrome
Lead Sponsor:
University Hospital, Strasbourg, France
Conditions:
Deglutition Disorders
Eligibility:
All Genders
18+ years
Brief Summary
R-CPD syndrome (Retrograde Cricopharyngeal Dysfunction syndrome) is an inability to burp. It is a syndrome whose diagnosis is clinical, and for which there is effective treatment. Recently treated in...
Eligibility Criteria
Inclusion
- Major subject (≥18 years old)
- Subject treated by injection of botulinum toxin into the cricopharyngeal muscle after having had a diagnosis of R-CPD in consultation between January 1, 2022 and December 31, 2022
- Subject not opposing the reuse of their data for the purposes of this research.
Exclusion
- Subject having expressed opposition to participating in the study,
- Subject under judicial protection
- Subject under guardianship or curatorship
Key Trial Info
Start Date :
February 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 19 2024
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06174831
Start Date
February 1 2023
End Date
January 19 2024
Last Update
December 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service d'ORL et de Chirurgie Cervico-faciale - CHU de Strasbourg - France
Strasbourg, France, 67091